Penicillin Allergy Delabeling Initiative Optimizes Abx, Savings

By Gina ShawA multidisciplinary penicillin allergy delabeling initiative safely removed the allergy designation in 96.4% of patients evaluated, optimized antibiotic therapy in nearly two-thirds, and produced an estimated $108,783 in inpatient cost savings over 12 months.Approximately 10% of patients report a penicillin allergy, yet roughly 90% of them are not truly allergic, noted Adnan Omanovic, PharmD, BCIDP, AAHIVP, an infectious diseases pharmacist at SSM Health, a 23-hospital nonprofit syst